ACETAZOLAMIDE SODIUM

Post-LOE

acetazolamide sodium

ANDAINJECTIONINJECTABLE
Approved
Jun 2025
Lifecycle
Post-LOE
Competitive Pressure
30/100

Mechanism of Action

CLINICAL PHARMACOLOGY Acetazolamide is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion (e.g., some types of glaucoma), in the treatment of certain convulsive disorders (e.g., epilepsy) and in the promotion of diuresis in instances of abnormal fluid retention…

Indications (2)